Physician profile
Daniel M Hanono
NPI 1679708242
$12,982.25
in general payments reported to CMS, 2019-2025
43 companies · $1,774 in 2025
The $1,774 reported for 2025 was more than what 80% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,885 · 2020: $682 · 2021: $1,733 · 2022: $1,988 · 2023: $2,174 · 2024: $2,748 · 2025: $1,774.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,695.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,021.16 | 2021-2025 | |
| Boston Scientific Corporation | $1,793.85 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,660.77 | 2019-2025 | Relistor |
| Forte Bio-Pharma LLC | $1,373.07 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Amgen INC. | $1,343.55 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $615.67 | 2020-2025 | Xtampza |
| Idorsia Pharmaceuticals US INC | $442.51 | 2023-2024 | Quviviq |
| Pfizer INC. | $332.55 | 2021-2025 | |
| Nevro Corp. | $246.40 | 2020-2022 | |
| Scilex Pharmaceuticals INC. | $202.53 | 2019-2025 | |
| Medtronic USA, INC. | $199.08 | 2019 | |
| Glaxosmithkline, LLC. | $120.45 | 2019 | |
| Globus Medical, INC. | $118.90 | 2025 | Senza |
| Redhill Biopharma INC. | $116.20 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $103.64 | 2019-2021 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hanono listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.